An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining promotional offers.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and assertions of next-day UK delivery. Vendors market the substance there before directing customers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could lead to users administering substances of uncertain source.
Some experts stated the popularity for retatrutide could be linked to the rising price of approved slimming products such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the British medical regulations.
Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison.
Platform Response and Content Removal
According to TikTok, the platform has taken down problematic content and banned associated hashtags and query recommendations. The company said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Investigations also discovered groups with up to nine thousand members selling retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, positive testimonials and step-by-step guides for preparing or injecting at home.
After moments of entering one group, a seller shared contact information, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, health issues or past usage.
Item Details and Pricing
Within these groups, posts display black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service stated it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is sound, these digital versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor linked the surge in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.
Her team has already encountered patients injured by personal administration from unverified sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially significant health risks”.
